Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
- PMID: 10709732
- DOI: 10.1203/00006450-200003000-00009
Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by autoimmune features and lymphoproliferations and is generally caused by defective Fas-mediated apoptosis. This report describes a child with clinical features of ALPS without detectable Fas expression on freshly isolated blood leukocytes. Detection of FAS transcripts via real-time quantitative PCR made a severe transcriptional defect unlikely. Sequencing of the FAS gene revealed a 20-nucleotide duplication in the last exon affecting the cytoplasmic signaling domain. The patient was homozygous for this mutation, whereas the consanguineous parents and the siblings were heterozygous. The patient reported here is a human homologue of the Fas-null mouse, inasmuch as she carries an autosomal homozygous mutation in the FAS gene and she shows the severe and accelerated ALPS phenotype. The heterozygous family members did not have the ALPS phenotype, indicating that the disease-causing FAS mutation in this family is autosomal recessive.
Similar articles
-
A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.Curr Allergy Asthma Rep. 2001 Nov;1(6):534-40. doi: 10.1007/s11882-001-0062-y. Curr Allergy Asthma Rep. 2001. PMID: 11895618 Review.
-
Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.Blood Cells Mol Dis. 1999 Jun-Aug;25(3-4):227-38. doi: 10.1006/bcmd.1999.0248. Blood Cells Mol Dis. 1999. PMID: 10575548
-
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.Blood. 2006 Aug 15;108(4):1306-12. doi: 10.1182/blood-2006-04-015776. Epub 2006 Apr 20. Blood. 2006. PMID: 16627752
-
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.Cell. 1995 Jun 16;81(6):935-46. doi: 10.1016/0092-8674(95)90013-6. Cell. 1995. PMID: 7540117
-
Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.J Leukoc Biol. 2018 Mar;103(3):501-508. doi: 10.1002/JLB.5MR0817-332R. Epub 2017 Dec 27. J Leukoc Biol. 2018. PMID: 29345341 Review.
Cited by
-
Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous FAS variant effectively treated with sirolimus.Front Pediatr. 2023 Apr 20;11:1150179. doi: 10.3389/fped.2023.1150179. eCollection 2023. Front Pediatr. 2023. PMID: 37152306 Free PMC article.
-
A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.Curr Allergy Asthma Rep. 2001 Nov;1(6):534-40. doi: 10.1007/s11882-001-0062-y. Curr Allergy Asthma Rep. 2001. PMID: 11895618 Review.
-
A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.J Clin Immunol. 2012 Dec;32(6):1197-203. doi: 10.1007/s10875-012-9731-y. Epub 2012 Jul 3. J Clin Immunol. 2012. PMID: 22752343
-
The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.J Clin Immunol. 2018 Jul;38(5):558-568. doi: 10.1007/s10875-018-0523-x. Epub 2018 Jun 17. J Clin Immunol. 2018. PMID: 29911256 Review.
-
Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.J Allergy Clin Immunol. 2024 Jan;153(1):67-76. doi: 10.1016/j.jaci.2023.11.004. Epub 2023 Nov 17. J Allergy Clin Immunol. 2024. PMID: 37977527 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous